Skip to main content

Table 1 Children involved in this study. Characteristics of included children at last follow-up (FU)

From: Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases

DemographicADS n = 27MS n = 10ADEM n = 5ADS MOG+ n = 6Others n = 6
Sex M/F6: 211: 91: 42: 42: 4
Age years, mean, SD11.1 ± 4.112.8 ± 1.97.9 ± 5.58.9 ± 4.313.1 ± 2.6
EDSS mean, SD0.7 ± 1.21.4 ± 1.60 ± 00.7 ± 0.80 ± 0
CSF     
Cell > 10 mm3113251
Prot >  0.5 g/dL73121
OCB (n = 22)86/101/31/50/4
FU years, mean, SD3.0 ± 1.63.5 ± 1.23.2 ± 0.93.8 ± 2.31.3 ± 0.7
Anti-AQP400000
Anti-MOG120165
  1. ADS acquired demyelinating syndrome, MS multiple sclerosis, ADEM acute demyelinating encephalomyelitis, ADS MOG+ non-MS relapsing demyelinating diseases with anti-MOG-Abs, Others:optic neuritis (n = 3), transverse myelitis (n = 2), hemiplegia (n = 1). Expanded Disability Status Scale (EDSS), oligo-clonal bands (OCB), follow-up (FU)